NCT06844383 · Interventional trial
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Overall registry status Recruiting
Phase 2
Conditions Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer)
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory